Ana sayfa
Piyasalar
Grafikler ve fikirler
Algo
Haberler
Store
Aracı kurumlar
İndir
Ekonomik Takvim
Alım-satım sinyalleri
Web Terminali
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
MGNX
#3184
MacroGenics, Inc.
1.9
9
+1.53%
Sektör:
Baz:
Kar para birimi:
Günlük aralık
Yıllık aralık
Günlük değişim
+1.53%
Aylık değişim
+8.15%
6 aylık değişim
+13.71%
Yıllık değişim
-17.43%
Önceki kapanış
1.9
6
Open
1.9
9
Bid
Ask
Low
1.9
9
High
1.9
9
Hacim
16
Piyasalar
ABD hisse senetleri
Sağlık hizmetleri
MGNX
Open full chart
Financials
Overview
Rapor
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
56.26 M
61.32 M
61.84 M
62.43 M
63.09 M
—
Valuation ratios
Enterprise value
1.1 B
860.79 M
284.41 M
534.6 M
22.2 M
-71.3 M
Price to earnings ratio
—
-4.76
-3.26
-67.87
-3.04
-8.05
Price to sales ratio
—
12.42
2.57
10.73
1.36
3.17
Price to cash flow ratio
—
-6.69
-4.49
-8.06
-2.98
-5.83
Price to book ratio
—
4.02
2.75
4.13
1.75
2.52
Enterprise value to EBITDA ratio
—
37.36
2.8
34.06
0.26
-0.59
Profitability ratios
Return on assets %
0.34
0.6
0.43
0.03
0.26
0.02
Return on equity %
0.44
0.84
0.84
0.06
0.58
0.71
Return on invested capital %
338.26
510.33
323.56
442.07
386.54
—
Gross margin %
100
96.58
97.79
98.95
99.44
398.8
Operating margin %
124.96
261.85
79.91
286.38
73.74
226.96
EBITDA margin %
—
29.75
66.81
26.72
57.12
153.49
Net margin %
123.7
260.97
78.82
15.42
44.66
-5.08
Liquidity ratios
Quick ratio
—
3.69
4.54
4.46
3.92
17.07
Current ratio
6.17
3.75
4.57
4.48
3.92
17.68
Inventory turnover
—
0.6
1.15
0.46
1.39
0.14
Asset turnover
0.3
0.22
0.49
0.2
0.54
0.5
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
2.4
1.42
1.26
1.09
2.58
EBIT per share
—
0.2
1.46
0.1
1.25
1.1
EBITDA per share
—
0.38
1.65
0.25
1.37
1.22
Total debt per share
—
—
—
—
—
—
Cash per share
—
2.06
1.77
1.63
2.92
8.57
Net current asset value per share
—
4.66
3.62
4.06
3.47
13.28
Tangible book value per share
—
4
2.31
2.46
1.85
4.91
Working capital per share
—
3.42
2.83
3.15
2.59
10.19
Book value per share
—
4
2.31
2.46
1.85
4.91
Haberler
BioLife Solutions, Inc. (BLFS) Surpasses Q4 Earnings and Revenue Estimates
MacroGenics hisseleri FDA’nın kısmi klinik durdurma kararıyla düştü
MacroGenics stock falls after FDA places partial clinical hold
Why Is MacroGenics Stock Sinking Tuesday? - Macrogenics (NASDAQ:MGNX)
Sanofi's Teizeild Gets EU Approval for Treating Type 1 Diabetes
FDA Accepts SNY Filing for Expanded Use of T1D Drug in Young Children
Thanksgiving: Top 10 Most Innovative BioPharma Drugs In Phase 3
MacroGenics (MGNX) Q3 Earnings and Revenues Surpass Estimates
MacroGenics Inc kazancı $0,68 ile beklentilere göre daha iyi, kâr ise beklentilere göre yüksek
MacroGenics Inc earnings beat by $0.68, revenue topped estimates
MacroGenics (MGNX) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
Stryker (SYK) Q3 Earnings and Revenues Beat Estimates